Calvin B. Harley

42.2k total citations · 14 hit papers
112 papers, 33.5k citations indexed

About

Calvin B. Harley is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Calvin B. Harley has authored 112 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Physiology, 57 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Calvin B. Harley's work include Telomeres, Telomerase, and Senescence (71 papers), Genetics, Aging, and Longevity in Model Organisms (17 papers) and RNA Interference and Gene Delivery (15 papers). Calvin B. Harley is often cited by papers focused on Telomeres, Telomerase, and Senescence (71 papers), Genetics, Aging, and Longevity in Model Organisms (17 papers) and RNA Interference and Gene Delivery (15 papers). Calvin B. Harley collaborates with scholars based in United States, Canada and United Kingdom. Calvin B. Harley's co-authors include Carol W. Greider, A. B. Futcher, Woodring E. Wright, Jerry W. Shay, Scott L. Weinrich, Richard Allsopp, Michael D. West, Gregg B. Morin, Nam W. Kim and Mieczyslaw A. Piatyszek and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Calvin B. Harley

109 papers receiving 32.6k citations

Hit Papers

Specific Association of H... 1987 2026 2000 2013 1994 1990 1998 1997 1995 1000 2.0k 3.0k 4.0k 5.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Calvin B. Harley 22.4k 18.7k 3.9k 3.4k 3.4k 112 33.5k
Carol W. Greider 26.3k 1.2× 20.3k 1.1× 5.2k 1.3× 2.2k 0.6× 2.7k 0.8× 116 34.5k
Woodring E. Wright 24.4k 1.1× 28.4k 1.5× 4.4k 1.1× 2.9k 0.8× 4.1k 1.2× 294 43.5k
Jerry W. Shay 32.2k 1.4× 35.3k 1.9× 5.1k 1.3× 4.3k 1.3× 5.2k 1.5× 522 58.0k
Peter M. Lansdorp 13.5k 0.6× 15.0k 0.8× 2.5k 0.6× 5.4k 1.6× 3.1k 0.9× 272 30.8k
Jan H.J. Hoeijmakers 5.2k 0.2× 38.1k 2.0× 2.6k 0.7× 2.2k 0.6× 5.8k 1.7× 399 48.0k
Michael N. Hall 3.9k 0.2× 34.3k 1.8× 1.9k 0.5× 3.7k 1.1× 3.7k 1.1× 246 44.9k
Scott W. Lowe 6.6k 0.3× 50.1k 2.7× 1.1k 0.3× 8.5k 2.5× 4.2k 1.3× 325 69.6k
Michael D. West 6.8k 0.3× 8.2k 0.4× 803 0.2× 976 0.3× 1.6k 0.5× 120 14.1k
Shelley L. Berger 3.0k 0.1× 26.7k 1.4× 1.5k 0.4× 3.1k 0.9× 4.6k 1.4× 233 35.9k
David Beach 3.4k 0.2× 34.4k 1.8× 817 0.2× 3.7k 1.1× 3.5k 1.0× 247 47.3k

Countries citing papers authored by Calvin B. Harley

Since Specialization
Citations

This map shows the geographic impact of Calvin B. Harley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin B. Harley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin B. Harley more than expected).

Fields of papers citing papers by Calvin B. Harley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin B. Harley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin B. Harley. The network helps show where Calvin B. Harley may publish in the future.

Co-authorship network of co-authors of Calvin B. Harley

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin B. Harley. A scholar is included among the top collaborators of Calvin B. Harley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin B. Harley. Calvin B. Harley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saux, Claude Jourdan Le, Philip Davy, Christopher Brampton, et al.. (2013). A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis. PLoS ONE. 8(3). e58423–e58423. 60 indexed citations
2.
Castelo‐Branco, Pedro, Cindy Zhang, Tatiana Lipman, et al.. (2011). Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition. Clinical Cancer Research. 17(1). 111–121. 35 indexed citations
3.
Tressler, Robert, Ekaterina Bassett, Calvin B. Harley, et al.. (2010). The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines. Cancer Research. 70(22). 9494–9504. 107 indexed citations
4.
Harley, Calvin B., Wei‐Min Liu, Marı́a A. Blasco, et al.. (2010). A Natural Product Telomerase Activator As Part of a Health Maintenance Program. Rejuvenation Research. 14(1). 45–56. 138 indexed citations
5.
Jamieson, Beth D., Allison C. Chin, Ronald T. Mitsuyasu, et al.. (2008). Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes. The Journal of Immunology. 181(10). 7400–7406. 135 indexed citations
6.
Harley, Calvin B.. (2007). Human Ageing and Telomeres. Novartis Foundation symposium. 211. 129–147. 30 indexed citations
7.
Matsui, William, Qiuju Wang, Sarah Brennan, et al.. (2007). The novel telomerase inhibitor GRN163L targets drug-resistant cancer stem cells in multiple myeloma. Molecular Cancer Therapeutics. 6. 1 indexed citations
8.
O’Sullivan, Jacintha, Jennifer C. Finley, Katherine A. Gollahon, et al.. (2004). Telomere length assessment in tissue sections by quantitative FISH: Image analysis algorithms. Cytometry Part A. 58A(2). 120–131. 71 indexed citations
9.
Sidorov, Igor A., et al.. (2003). Cancer treatment by telomerase inhibitors: predictions by a kinetic model. Mathematical Biosciences. 181(2). 209–221. 11 indexed citations
10.
Craig, Karen & Calvin B. Harley. (1996). Phosphorylation of human pleckstrin on Ser-113 and Ser-117 by protein kinase C. Biochemical Journal. 314(3). 937–942. 24 indexed citations
11.
Harley, Calvin B.. (1995). 9 Telomeres and Aging. Cold Spring Harbor Monograph Archive. 29. 247–263. 66 indexed citations
12.
Kim, Nam W., Mieczyslaw A. Piatyszek, Karen R. Prowse, et al.. (1994). Specific Association of Human Telomerase Activity with Immortal Cells and Cancer. Science. 266(5193). 2011–2015. 5978 indexed citations breakdown →
13.
Harley, Calvin B., Karen R. Prowse, Scott L. Weinrich, et al.. (1994). Telomerase, Cell Immortality, and Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 307–315. 342 indexed citations breakdown →
14.
Harley, Calvin B., et al.. (1990). Reiterative copying byE.coliRNA polymerase during transcription initiation of mutant pBR322 tet promoters. Nucleic Acids Research. 18(3). 547–552. 19 indexed citations
15.
Tyers, Michael, Richard J. Haslam, Richard A. Rachubinski, & Calvin B. Harley. (1989). Molecular analysis of pleckstrin: The major protein kinase c substrate of platelets. Journal of Cellular Biochemistry. 40(2). 133–145. 60 indexed citations
16.
Tyers, Michael, Richard A. Rachubinski, Angela Varrichio, et al.. (1988). Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 333(6172). 470–473. 210 indexed citations
17.
Sauder, Daniel N., et al.. (1988). Biology and Molecular Biology of Epidermal Cell‐Derived Thymocyte Activating Factora. Annals of the New York Academy of Sciences. 548(1). 241–252. 6 indexed citations
18.
Harley, Calvin B., et al.. (1988). Transcription initiation at thetetpromoter and effect of mutations. Nucleic Acids Research. 16(15). 7269–7285. 9 indexed citations
19.
Tron, Victor A., Calvin B. Harley, Deoraj Caussy, & Daniel N. Sauder. (1988). In situ detection of interleukin-1 mRNA in human monocytes. Molecular Immunology. 25(5). 439–445. 10 indexed citations
20.
Harley, Calvin B.. (1987). Hybridization of Oligo(dT) to RNA on nitrocellulose. PubMed. 4(2). 17–22. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026